questionsmedicales.fr
Maladies métaboliques et nutritionnelles
Maladies métaboliques
Erreurs innées du métabolisme
Erreurs innées du métabolisme lipidique
Erreurs innées du métabolisme lipidique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Erreurs innées du métabolisme lipidique : Questions médicales les plus fréquentes",
"headline": "Erreurs innées du métabolisme lipidique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Erreurs innées du métabolisme lipidique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Erreurs innées du métabolisme lipidique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Erreurs innées du métabolisme",
"url": "https://questionsmedicales.fr/mesh/D008661",
"about": {
"@type": "MedicalCondition",
"name": "Erreurs innées du métabolisme",
"code": {
"@type": "MedicalCode",
"code": "D008661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Barth",
"alternateName": "Barth Syndrome",
"url": "https://questionsmedicales.fr/mesh/D056889",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Barth",
"code": {
"@type": "MedicalCode",
"code": "D056889",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.224"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipidémie familiale mixte",
"alternateName": "Hyperlipidemia, Familial Combined",
"url": "https://questionsmedicales.fr/mesh/D006950",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipidémie familiale mixte",
"code": {
"@type": "MedicalCode",
"code": "D006950",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type I",
"alternateName": "Hyperlipoproteinemia Type I",
"url": "https://questionsmedicales.fr/mesh/D008072",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type I",
"code": {
"@type": "MedicalCode",
"code": "D008072",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.465"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type II",
"alternateName": "Hyperlipoproteinemia Type II",
"url": "https://questionsmedicales.fr/mesh/D006938",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type II",
"code": {
"@type": "MedicalCode",
"code": "D006938",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.481"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypercholestérolémie familiale homozygote",
"alternateName": "Homozygous Familial Hypercholesterolemia",
"url": "https://questionsmedicales.fr/mesh/D000090542",
"about": {
"@type": "MedicalCondition",
"name": "Hypercholestérolémie familiale homozygote",
"code": {
"@type": "MedicalCode",
"code": "D000090542",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.481.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type III",
"alternateName": "Hyperlipoproteinemia Type III",
"url": "https://questionsmedicales.fr/mesh/D006952",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type III",
"code": {
"@type": "MedicalCode",
"code": "D006952",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.483"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type IV",
"alternateName": "Hyperlipoproteinemia Type IV",
"url": "https://questionsmedicales.fr/mesh/D006953",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type IV",
"code": {
"@type": "MedicalCode",
"code": "D006953",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.487"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hyperlipoprotéinémie de type V",
"alternateName": "Hyperlipoproteinemia Type V",
"url": "https://questionsmedicales.fr/mesh/D006954",
"about": {
"@type": "MedicalCondition",
"name": "Hyperlipoprotéinémie de type V",
"code": {
"@type": "MedicalCode",
"code": "D006954",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.493"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypolipoprotéinémies",
"alternateName": "Hypolipoproteinemias",
"url": "https://questionsmedicales.fr/mesh/D007009",
"about": {
"@type": "MedicalCondition",
"name": "Hypolipoprotéinémies",
"code": {
"@type": "MedicalCode",
"code": "D007009",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypoalphalipoprotéinémies",
"alternateName": "Hypoalphalipoproteinemias",
"url": "https://questionsmedicales.fr/mesh/D052456",
"about": {
"@type": "MedicalCondition",
"name": "Hypoalphalipoprotéinémies",
"code": {
"@type": "MedicalCode",
"code": "D052456",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Déficit en lécithine-cholestérol-acyl-transférase",
"alternateName": "Lecithin Cholesterol Acyltransferase Deficiency",
"url": "https://questionsmedicales.fr/mesh/D007863",
"about": {
"@type": "MedicalCondition",
"name": "Déficit en lécithine-cholestérol-acyl-transférase",
"code": {
"@type": "MedicalCode",
"code": "D007863",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tangier",
"alternateName": "Tangier Disease",
"url": "https://questionsmedicales.fr/mesh/D013631",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tangier",
"code": {
"@type": "MedicalCode",
"code": "D013631",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Déficit en lécithine-cholestérol-acyl-transférase",
"alternateName": "Lecithin Cholesterol Acyltransferase Deficiency",
"url": "https://questionsmedicales.fr/mesh/D007863",
"about": {
"@type": "MedicalCondition",
"name": "Déficit en lécithine-cholestérol-acyl-transférase",
"code": {
"@type": "MedicalCode",
"code": "D007863",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Tangier",
"alternateName": "Tangier Disease",
"url": "https://questionsmedicales.fr/mesh/D013631",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Tangier",
"code": {
"@type": "MedicalCode",
"code": "D013631",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.330.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypobêtalipoprotéinémies",
"alternateName": "Hypobetalipoproteinemias",
"url": "https://questionsmedicales.fr/mesh/D006995",
"about": {
"@type": "MedicalCondition",
"name": "Hypobêtalipoprotéinémies",
"code": {
"@type": "MedicalCode",
"code": "D006995",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.440"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Abêtalipoprotéinémie",
"alternateName": "Abetalipoproteinemia",
"url": "https://questionsmedicales.fr/mesh/D000012",
"about": {
"@type": "MedicalCondition",
"name": "Abêtalipoprotéinémie",
"code": {
"@type": "MedicalCode",
"code": "D000012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.440.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Abêtalipoprotéinémie",
"alternateName": "Abetalipoproteinemia",
"url": "https://questionsmedicales.fr/mesh/D000012",
"about": {
"@type": "MedicalCondition",
"name": "Abêtalipoprotéinémie",
"code": {
"@type": "MedicalCode",
"code": "D000012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.500.440.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Lipidoses",
"alternateName": "Lipidoses",
"url": "https://questionsmedicales.fr/mesh/D008064",
"about": {
"@type": "MedicalCondition",
"name": "Lipidoses",
"code": {
"@type": "MedicalCode",
"code": "D008064",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.641"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Céroïdes-lipofuscinoses neuronales",
"alternateName": "Neuronal Ceroid-Lipofuscinoses",
"url": "https://questionsmedicales.fr/mesh/D009472",
"about": {
"@type": "MedicalCondition",
"name": "Céroïdes-lipofuscinoses neuronales",
"code": {
"@type": "MedicalCode",
"code": "D009472",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.641.509"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Sjögren-Larsson",
"alternateName": "Sjogren-Larsson Syndrome",
"url": "https://questionsmedicales.fr/mesh/D016111",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Sjögren-Larsson",
"code": {
"@type": "MedicalCode",
"code": "D016111",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.641.723"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Xanthomatose cérébrotendineuse",
"alternateName": "Xanthomatosis, Cerebrotendinous",
"url": "https://questionsmedicales.fr/mesh/D019294",
"about": {
"@type": "MedicalCondition",
"name": "Xanthomatose cérébrotendineuse",
"code": {
"@type": "MedicalCode",
"code": "D019294",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.648.398.925"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Erreurs innées du métabolisme lipidique",
"alternateName": "Lipid Metabolism, Inborn Errors",
"code": {
"@type": "MedicalCode",
"code": "D008052",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Carlos R Ferreira",
"url": "https://questionsmedicales.fr/author/Carlos%20R%20Ferreira",
"affiliation": {
"@type": "Organization",
"name": "Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States; Rare Disease Institute, Children's National Health System, Washington, DC, United States."
}
},
{
"@type": "Person",
"name": "Clara D M van Karnebeek",
"url": "https://questionsmedicales.fr/author/Clara%20D%20M%20van%20Karnebeek",
"affiliation": {
"@type": "Organization",
"name": "Departments of Pediatrics and Clinical Genetics, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Department of Pediatrics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada. Electronic address: c.d.vankarnebeek@amstedarmumc.nl."
}
},
{
"@type": "Person",
"name": "Jerry Vockley",
"url": "https://questionsmedicales.fr/author/Jerry%20Vockley",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, University of Pittsburgh School of Medicine, Department of Human Genetics, Graduate School of Public Health, Pittsburgh, Pennsylvania, USA."
}
},
{
"@type": "Person",
"name": "Andrea L Gropman",
"url": "https://questionsmedicales.fr/author/Andrea%20L%20Gropman",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Children's National, Washington, DC 20010, USA."
}
},
{
"@type": "Person",
"name": "Sumreena Mansoor",
"url": "https://questionsmedicales.fr/author/Sumreena%20Mansoor",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Shifa College of Medicine, Shifa Tameer-e-millat university, H-8/4, Islamabad, Pakistan. dr.sumreena@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Multidrug stewardship and adherence to guidelines in >200,000 direct-to-consumer Telemedicine encounters.",
"datePublished": "2024-07-08",
"url": "https://questionsmedicales.fr/article/38985017",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31744/einstein_journal/2024AO0707"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adherence to Nutritional Practice Guideline in Premature Infants: A Nationwide Survey in Taiwan.",
"datePublished": "2024-09-20",
"url": "https://questionsmedicales.fr/article/39339781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu16183181"
}
},
{
"@type": "ScholarlyArticle",
"name": "Timely cholecystectomy: important factors to improve guideline adherence and patient treatment.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39053927",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjgast-2024-001439"
}
},
{
"@type": "ScholarlyArticle",
"name": "Quality improvement project to improve adherence to lung protective ventilation guidelines.",
"datePublished": "2024-05-24",
"url": "https://questionsmedicales.fr/article/38789280",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjoq-2023-002638"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adherence to 24-h movement behaviour guidelines in families with multiple children.",
"datePublished": "2023-12-17",
"url": "https://questionsmedicales.fr/article/38105630",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cch.13213"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies métaboliques et nutritionnelles",
"item": "https://questionsmedicales.fr/mesh/D009750"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies métaboliques",
"item": "https://questionsmedicales.fr/mesh/D008659"
},
{
"@type": "ListItem",
"position": 4,
"name": "Erreurs innées du métabolisme",
"item": "https://questionsmedicales.fr/mesh/D008661"
},
{
"@type": "ListItem",
"position": 5,
"name": "Erreurs innées du métabolisme lipidique",
"item": "https://questionsmedicales.fr/mesh/D008052"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Erreurs innées du métabolisme lipidique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Erreurs innées du métabolisme lipidique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Erreurs innées du métabolisme lipidique",
"description": "Comment diagnostique-t-on une erreur métabolique lipidique ?\nQuels tests sont utilisés pour le diagnostic ?\nLes symptômes aident-ils au diagnostic ?\nQuelle est l'importance de l'histoire familiale ?\nPeut-on utiliser l'imagerie pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Guideline+Adherence&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Erreurs innées du métabolisme lipidique",
"description": "Quels sont les symptômes courants ?\nLes symptômes varient-ils selon le type d'erreur ?\nY a-t-il des signes cutanés associés ?\nLes symptômes apparaissent-ils à la naissance ?\nLes troubles mentaux sont-ils possibles ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Guideline+Adherence&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Erreurs innées du métabolisme lipidique",
"description": "Peut-on prévenir ces erreurs ?\nLe conseil génétique est-il utile ?\nLes vaccinations sont-elles importantes ?\nLes tests prénataux sont-ils recommandés ?\nL'éducation des parents est-elle cruciale ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Guideline+Adherence&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Erreurs innées du métabolisme lipidique",
"description": "Quels traitements sont disponibles ?\nLa diététique joue-t-elle un rôle ?\nDes médicaments sont-ils utilisés ?\nLa thérapie génique est-elle une option ?\nLes greffes d'organes sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Guideline+Adherence&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Erreurs innées du métabolisme lipidique",
"description": "Quelles complications peuvent survenir ?\nLes erreurs lipidique peuvent-elles être mortelles ?\nY a-t-il des risques de cancer ?\nLes troubles psychologiques sont-ils fréquents ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Guideline+Adherence&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Erreurs innées du métabolisme lipidique",
"description": "Quels sont les facteurs de risque génétiques ?\nL'origine ethnique influence-t-elle le risque ?\nL'alimentation joue-t-elle un rôle ?\nLes infections peuvent-elles aggraver la condition ?\nLe sexe influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D008052?mesh_terms=Guideline+Adherence&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une erreur métabolique lipidique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, des analyses génétiques et des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage néonatal, des dosages enzymatiques et des analyses d'urine sont courants."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent le diagnostic et peuvent indiquer le type d'erreur."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'histoire familiale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'histoire familiale aide à identifier les risques génétiques et à orienter les tests."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à évaluer les organes affectés, mais n'est pas spécifique."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs abdominales, troubles neurologiques et retard de croissance."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'erreur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type d'erreur lipidique présente des symptômes spécifiques et variés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines erreurs peuvent provoquer des dépôts lipidiques visibles sur la peau."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à la naissance ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent apparaître dès la naissance, d'autres se développent plus tard."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux sont-ils possibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs et comportementaux peuvent survenir dans certaines erreurs."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir ces erreurs ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est limitée, mais le dépistage néonatal peut aider à identifier les cas précoces."
}
},
{
"@type": "Question",
"name": "Le conseil génétique est-il utile ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le conseil génétique aide les familles à comprendre les risques et les options de dépistage."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas les erreurs métaboliques, mais protègent contre d'autres maladies."
}
},
{
"@type": "Question",
"name": "Les tests prénataux sont-ils recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests prénataux peuvent être proposés pour détecter certaines erreurs génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation des parents est-elle cruciale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les parents sur les signes et symptômes peut aider à une détection précoce."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des régimes alimentaires spécifiques, des suppléments et des médicaments."
}
},
{
"@type": "Question",
"name": "La diététique joue-t-elle un rôle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime adapté est crucial pour gérer les niveaux de lipides et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils utilisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour réduire les niveaux de lipides ou traiter les symptômes."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche pour certaines erreurs, mais n'est pas encore courante."
}
},
{
"@type": "Question",
"name": "Les greffes d'organes sont-elles nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas graves, des greffes peuvent être envisagées pour traiter des dommages organiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies hépatiques, des troubles neurologiques et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Les erreurs lipidique peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines erreurs peuvent entraîner des complications graves pouvant être fatales sans traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines erreurs peuvent augmenter le risque de développer certains types de cancer."
}
},
{
"@type": "Question",
"name": "Les troubles psychologiques sont-ils fréquents ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques peuvent survenir en raison de l'impact des symptômes."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes sans traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque génétiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux d'erreurs métaboliques augmentent le risque de transmission."
}
},
{
"@type": "Question",
"name": "L'origine ethnique influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines erreurs sont plus fréquentes dans des populations spécifiques en raison de la génétique."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée peut exacerber les symptômes chez les individus prédisposés."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver la condition ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent déclencher ou aggraver les symptômes des erreurs métaboliques."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines erreurs métaboliques peuvent avoir une prévalence différente selon le sexe."
}
}
]
}
]
}
The quality of care and safety for Telemedicine-discharged patients with suspected respiratory infections are closely related to low rates of prescriptions of unjustified and high-risk medications. Th...
A quarterly electronic survey utilizing medical records of individual physician care assessed various quality indicators. Physicians received ongoing adaptive feedback based on personal metrics, with ...
Of the 221,128 evaluated patients, 42,042 (19%) had confirmed COVID-19; 104,021 (47%) were suspected to have COVID-19; and, 75,065 (33%) had other diagnoses. Patients with suspected or confirmed COVID...
Guideline training and Telemedicine consultation feedback may lead to lower antibiotic and antimicrobial prescriptions in suspected and confirmed COVID-19 cases. Multidrug stewardship protocols may im...
This study aimed to assess the current neonatal nutritional practices in Taiwan and promote consensus on standardized protocols....
An online questionnaire comprising 95 items on parenteral nutrition (PN) and enteral nutrition (EN) practices was distributed to neonatal care units across Taiwan via email between August and December...
Most of the 35 neonatal units, comprising 17 level III and 18 level II units, that participated in this study adhered to standard PN protocols; however, only 30% of units used protein-containing solut...
Most nutrient protocols for preterm infants in neonatal units in Taiwan meet recent guidelines, but discrepancies such as lower mineral supplements in PN and a slower advancement of enteral feeding in...
Cholecystectomy is one of the most frequently performed surgeries in Germany and is performed as a treatment of acute cholecystitis (guideline S3 IIIB.8) and after endoscopic retrograde cholangiopancr...
Methodologically, a retrospective analysis based on routine billing data from 84 Helios Group hospitals from 2016 and 2022, with a total of 45 393 included cases, was applied. The guideline adherence ...
Results show the guideline updates led to a statistically significant increase in the proportion of cholecystectomy performed in a timely manner (guideline S3 IIIB.8: increase from 43% to 49%, p<0.001...
As possible reasons for non-adherence, medical factors such as advanced age, multimorbidity and frailty could be identified. Analyses of structural factors revealed that hospitals in very rural region...
Lung protective ventilation (LPV) is advocated for all patients requiring mechanical ventilation (MV), for any duration of time, to prevent worsening lung injury. Previous studies proved simple interv...
To assess the impact of a multi-component LPV quality improvement project (QIP) on adherence to LPV guidelines....
Tidal volume data for all patients requiring MV at a large, tertiary UK critical care unit were collected retrospectively over 3, 6 months, Plan-Do-Study-Act cycles between September 2019 and August 2...
Adherence against predetermined targets of <5% of MV hours spent at >10 mL/kg predicted body weight (PBW) and >75% of MV hours spent <8 mL/kg PBW for all patients requiring MV....
408 949 hours (17 040 days) of MV data were analysed. Improved LPV adherence was demonstrated throughout the QIP. During mandated MV, time spent >10 mL/kg PBW reduced from 7.65% of MV hours to 4.04% a...
This multicomponent intervention including the use of LPV reports, bedside whiteboards and education improves adherence to LPV guidelines. More robust data analysis of reasons for non-adherence to our...
In 2019, the World Health Organization (WHO) launched the first global movement guidelines for children that combined sleep, physical activity and screen time. Our previous research showed that adhere...
Data were from the 1973-1978 cohort of the Australian Longitudinal Study on Women's Health (seventh survey, 2015) and the women's three youngest children (aged ≤12) (Mothers and their Children's Healt...
Families with children in the same age guideline categories had double the odds of having all children meet 24-h movement guidelines (adjusted odds ratio [OR] 1.95 [95% confidence interval, CI: 1.32, ...
Families with multiple children may need practical advice and strategies on how to adhere to guidelines when children span age categories. This could form part of public health strategies that raise a...
Guideline-adherent physiotherapy can improve patient outcomes and reduce costs in the healthcare system. However, although there are numerous guidelines for physiotherapy practice, services are not co...
This scoping review will be based on Arksey and O'Malley's scoping review methodology and the methodological guidance for conducting scoping reviews published by Joanna Briggs Institute. Relevant publ...
This scoping review will provide an extensive overview of the barriers, facilitators and implementation strategies for guideline-adherent physiotherapy. As scoping reviews are a form of secondary data...
This scoping review has been registered on 3 April 2023 on the Open Science Framework under https://doi.org/10.17605/OSF.IO/SEUW6....
The objective of this analysis was to describe longitudinal adherence with recommended urinary incontinence (UI) evaluation and treatment guidelines over a 2-year period in patients newly diagnosed wi...
A retrospective claims analysis using the IBM MarketScan database was conducted. Women diagnosed with SUI/MUI between July 1, 2014 and June 30, 2016 were identified using the International Classificat...
103 813 patients with newly diagnosed SUI or MUI were identified. Of those, 96.15% (99 821/103 813) received an initial evaluation in accordance with professional guidelines (e.g., patient history, ph...
The majority of SUI or MUI patients do not receive a documented behavioral intervention as their first-line treatment, which is a recommendation by professional society guidelines. This was found to a...
Evaluating patients and treatment decisions in a multidisciplinary tumor board has led to better quality of care and longer survival in cancer patients. The aim of this study was to evaluate tumor boa...
We evaluated tumor board recommendations of the thoracic oncology tumor board at Ludwig-Maximilians University (LMU) Hospital Munich between 2014 and 2016. We compared patient characteristics between ...
Over 90% of recommendations by the tumor board were either adherent to the guidelines (75.5%) or over fulfilling guidelines (15.6%). Almost 90% of recommendations were transferred to clinical practice...
In conclusion, the results of this study are promising, as the guideline adherence of recommendations as well as the transferal of recommendations into clinical practice were high. In the future, a sp...
Evidence-based medicine is pivotal to contemporary clinical practice, and the excellence of a healthcare institution is measured by the adherence of its clinical staff to the clinical practice guideli...
To determine adherence to the 2017 American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) guidelines for the management and treatment of benign paroxysmal positional vertigo (BPPV) in prim...
Retrospective chart review....
Twenty-six clinic locations within a single healthcare system....
Charts of 458 patients diagnosed with BPPV in PC between 2018 and 2022 were reviewed. Encounters where the diagnosis of BPPV was made were identified. From the clinical encounter note, demographics, s...
Of 458 patients, 249 (54.4%) did not receive a diagnostic exam, and only 4 (0.9%) patients received imaging. Regarding treatment, only 51 (11.1%) received the Epley maneuver, with 263 (57.4%) receivin...
Our data suggest that there continue to be gaps in the adherence to AAO-HNS guidelines; however, these gaps did not differ by sex, race, or insurance status. Care should be taken to increase the use o...